Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.89 USD | -1.66% | -7.42% | -13.24% |
May. 14 | Leerink Partners Upgrades Enhabit to Market Perform From Underperform, Price Target is $8.50 | MT |
May. 10 | UBS Trims Price Target on Enhabit to $9 From $10, Keeps Neutral Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.24% | 453M | |
0.00% | 1.94B | |
+18.79% | 1.78B | |
+63.65% | 667M | |
-40.25% | 335M | |
-24.44% | 163M | |
-13.64% | 136M | |
+1.92% | 67.84M |
- Stock Market
- Equities
- EHAB Stock
- News Enhabit, Inc.
- Transcript : Enhabit, Inc. Presents at Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference, Mar-01-2023 12